AlphaCrest Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-28,994
| Closed | -$299K | – | 110 |
|
|
2022
Q3 | $299K | Sell |
28,994
-16,732
| -37% | -$173K | 0.02% | 1139 |
|
|
2022
Q2 | $458K | Buy |
45,726
+4,409
| +11% | +$44.2K | 0.02% | 984 |
|
|
2022
Q1 | $509K | Buy |
41,317
+28,326
| +218% | +$349K | 0.03% | 887 |
|
|
2021
Q4 | $225K | Sell |
12,991
-1,409
| -10% | -$24.4K | 0.01% | 1313 |
|
|
2021
Q3 | $258K | Buy |
+14,400
| New | +$258K | 0.01% | 1150 |
|